eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | adenocarcinoma of esophagus |
| Symptom | C0004763|barrett\'s oesophagus |
| Sentences | 6 |
| PubMedID- 24221456 | Background and aims: acid-suppressive medications, particularly proton pump inhibitors (ppis), may decrease the risk of oesophageal adenocarcinoma (oac) in patients with barrett's oesophagus (bo). |
| PubMedID- 22353776 | Observational data have also indicated that statins may have protective effects against the development of cancer, for example, modifying the risk of oesophageal adenocarcinoma in patients with existing barrett's oesophagus . |
| PubMedID- 21143918 | There are few clear prognostic indicators of susceptibility to developing oesophageal adenocarcinoma although patients with barrett's oesophagus are thought to be more at risk to developing oesophageal adenocarcinoma. |
| PubMedID- 26311716 | Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with barrett's oesophagus. |
| PubMedID- 20550712 | However, to date this hypothesis remains untested.the 'exercise and the prevention of oesophageal cancer study' will determine whether 24 weeks of exercise training will lead to alterations in risk factors or biomarkers for oesophageal adenocarcinoma in males with barrett's oesophagus. |
| PubMedID- 25633286 | Nsaids, statins, low-dose aspirin and ppis, and the risk of oesophageal adenocarcinoma among patients with barrett's oesophagus: a population-based case-control study. |
Page: 1